漢威科技(300007.SZ):主要業務產品為TO封裝激光器、蝶形封裝激光器器件的研發、生產和銷售
格隆匯1月9日丨漢威科技(300007.SZ)在投資者互動平台表示,公司近年來非常重視光電子產業發展,分別設立了鄭州威晶光電、鄭州新威光電以及威晶光電深圳分公司,建設了完整的光電子器件產線,實現光電子器件系列產品的覆蓋,主要業務產品為TO封裝激光器、蝶形封裝激光器器件的研發、生產和銷售。公司光電板塊核心技術人員及主要員工均來自光電器件製造行業,有着豐富的光電器件研發技術經驗和持續創新能力,未來公司將充分發揮中原總部研發創新、生產製造能力,同時發揮深圳激光器行業區位優勢與發展創新潛能,以自身全面的研發製造能力結合漢威科技集團總部的產業生態圈優勢,為客户提供完全自主可控的激光器器件及模組整體方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.